Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7

被引：1
|
作者：
Bauwens, Andreas [1 ]
Kunsmann, Lisa [1 ]
Karch, Helge [1 ,2 ]
Mellmann, Alexander [1 ,2 ]
Bielaszewska, Martina [1 ]
机构：
[1] Univ Munster, Inst Hyg, Munster, Germany
[2] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, Munster, Germany
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2017年 / 61卷 / 09期
关键词：
antibiotics; enterohemorrhagic E. coli; hemolytic uremic syndrome; outer membrane vesicles; Shiga toxins; HEMOLYTIC-UREMIC SYNDROME; SHIGA-TOXIN; PSEUDOMONAS-AERUGINOSA; STRAIN; INFECTION; OUTBREAK; GERMANY; RELEASE; RISK;
D O I：
10.1128/AAC.00937-17
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Ciprofloxacin, meropenem, fosfomycin, and polymyxin B strongly increase production of outer membrane vesicles (OMVs) in Escherichia coli O104:H4 and O157:H7. Ciprofloxacin also upregulates OMV-associated Shiga toxin 2a, the major virulence factor of these pathogens, whereas the other antibiotics increase OMV production without the toxin. These two effects might worsen the clinical outcome of infections caused by Shiga toxin-producing E. coli. Our data support the existing recommendations to avoid antibiotics for treatment of these infections.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Molecular Screening, Isolation, and Characterization of Enterohemorrhagic Escherichia coli O157:H7 from Retail Shrimp
    Surendraraj, Alagarsamy
    Thampuran, Nirmala
    Joseph, Toms C.
    JOURNAL OF FOOD PROTECTION, 2010, 73 (01) : 97 - 103
  • [42] Escherichia coli O104:H4 and Hemolytic Uremic Syndrome: The Analysis Begins
    Tarr, Phillip I.
    Karpman, Diana
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (06) : 760 - 763
  • [43] The 2011 German Enterohemorrhagic Escherichia Coli O104:H4 Outbreak-The Danger Is Still Out There
    Kampmeier, Stefanie
    Berger, Michael
    Mellmann, Alexander
    Karch, Helge
    Berger, Petya
    ESCHERICHIA COLI, A VERSATILE PATHOGEN, 2018, 416 : 117 - 148
  • [44] Occurrence and Antibiotic Resistance of Escherichia coli O157:H7 in a Watershed in North-Central Indiana
    Fincher, Laura M.
    Parker, Chelsea D.
    Chauret, Christian P.
    JOURNAL OF ENVIRONMENTAL QUALITY, 2009, 38 (03) : 997 - 1004
  • [45] Treatment options for HUS secondary to Escherichia coli O157:H7
    Bitzan, Martin
    KIDNEY INTERNATIONAL, 2009, 75 : S62 - S66
  • [46] Genomic anatomy of Escherichia coli O157:H7 outbreaks
    Eppinger, Mark
    Mammel, Mark K.
    Leclerc, Joseph E.
    Ravel, Jacques
    Cebula, Thomas A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (50) : 20142 - 20147
  • [47] Escherichia coli O157:H7 colonization in small domestic ruminants
    La Ragione, Roberto M.
    Best, Angus
    Woodward, Martin J.
    Wales, Andrew D.
    FEMS MICROBIOLOGY REVIEWS, 2009, 33 (02) : 394 - 410
  • [48] Annexin Induces Cellular Uptake of Extracellular Vesicles and Delays Disease in Escherichia coli O157:H7 Infection
    Tontanahal, Ashmita
    Arvidsson, Ida
    Karpman, Diana
    MICROORGANISMS, 2021, 9 (06)
  • [49] Effect of antibiotic-supplemented feed on fecal enterohemorrhagic Escherichia coli O157:H7 population in lambs
    Lema, A
    Nahashon, S
    SMALL RUMINANT RESEARCH, 2006, 63 (03) : 256 - 261
  • [50] Virulent Bacteriophages Can Target O104:H4 Enteroaggregative Escherichia coli in the Mouse Intestine
    Maura, Damien
    Galtier, Matthieu
    Le Bouguenec, Chantal
    Debarbieux, Laurent
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (12) : 6235 - 6242
12345